The ADHD system in the UK is in a state of crisis, leaving patients caught in a frustrating and often harmful limbo. It's a story of broken promises and a lack of coordination between private and NHS care, with devastating consequences for those seeking help.
Sameer Modha, a father and an ADHD patient himself, has witnessed this crisis firsthand. His experience highlights the challenges faced by many families navigating the ADHD diagnosis and treatment process.
Modha's journey began with a straightforward diagnosis for himself, but when it came to his eldest child, the system faltered. Despite obtaining a diagnosis from a highly respected professional, the NHS rejected it, citing non-compliance with national guidelines set by the National Institute for Health and Care Excellence (Nice).
This is not an isolated incident. The NHS, facing increasing demand, often refers patients to private providers, only to reject their assessments later. This inefficient cycle wastes public funds and leaves patients without the care they desperately need. One NHS trust described this churn as a major obstacle, preventing them from treating patients effectively.
But here's where it gets controversial... The NHS's 'right to choose' policy, which allows patients to opt for private assessment and treatment funded by the NHS, is meant to ease the burden on local services. However, in practice, this policy has created a fragmented system where care is often not seamlessly transferred back to the NHS.
Modha's daughter, diagnosed independently through a private provider, faced the same structural barriers when attempting to integrate her care back into the NHS. Trusts are reporting a growing number of patients assessed privately being sent back into NHS services, contributing to long waiting lists and a reduced capacity for new and complex cases.
The trust highlighted the lack of regulation surrounding private ADHD providers, noting that while they can establish services and diagnose ADHD, their assessments may not always meet Nice guidelines. This scheme, intended to relieve pressure on NHS services, seems to be recycling it instead.
Regulatory action has further exposed the risks. ADHDNet, a private provider operating under 'right to choose', has been suspended from NHS work due to concerns about service management, safety oversight, and continuity of care. This suspension underscores the challenges and limitations of a system that prioritizes quick diagnosis over consistent, high-quality care.
NHS Greater Manchester is facing particularly severe strain, with adult ADHD referrals skyrocketing by over 400% in just two years. Waiting times for autism and ADHD assessments now exceed seven years in some cases, far exceeding the designed capacity of these services.
The demand for ADHD support continues to outpace the available capacity, exacerbated by workforce shortages. NHS Greater Manchester estimates that funding current levels of 'right to choose' diagnostic requests alone would cost at least £30 million a year, without the necessary clinicians to deliver this care.
A key issue identified is the perception that diagnosis is the gateway to support, when in reality, many people need help that doesn't require a full specialist assessment. In response, NHS Greater Manchester is introducing a central triage hub, aiming to reduce full diagnostic assessments by 70-80%, standardize decisions, and alleviate pressure on specialist services.
Alongside this, the NHS plans to expand community-based and non-clinical support, allowing people to access help earlier while waiting for a formal diagnosis.
However, it's the patients who bear the brunt of this broken system. One father shared his son's experience, where after three years of treatment with a private provider, the GP practice suddenly stopped working with them, leaving his son facing waiting times exceeding six months and a guaranteed treatment gap.
Modha captures the essence of this dilemma: "You're damned if you do and damned if you don't." He questions the viability of seeking private help and integrating later, or waiting two years through the NHS, a wait that could be fatal for some.
The Independent Healthcare Providers Network (IHPN) acknowledges the essential role of independent providers in supporting NHS ADHD services but emphasizes the challenges of shared care and the risks to patients when coordination is lacking. They call for collaborative efforts between the government, NHS commissioners, relevant GP bodies, and independent providers to address these issues.
While regulatory concerns about safety, quality, and consistency of care are valid and must be addressed, the overarching challenge remains the longstanding lack of capacity and unacceptably long waiting times for diagnosis.
This crisis demands urgent attention and innovative solutions to ensure that patients receive the timely and effective care they deserve.
